WHO Immunization Implementation Guide
0.2.0 - ci-build
WHO Immunization Implementation Guide, published by WHO. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations/ and changes regularly. See the Directory of published versions
Language: en
LinkID | Text | Cardinality | Type | Description & Constraints |
---|---|---|---|---|
![]() ![]() | Questionnaire for IMMZ.D13.Update client record | Questionnaire | http://smart.who.int/immunizations/Questionnaire/QIMMZD13#0.2.0 | |
![]() ![]() ![]() | Birth dose | 1..1 | boolean | |
![]() ![]() ![]() | Type of dose | 1..1 | choice | Value Set: IMMZ.D.DE258 ValueSet for Type of dose |
![]() ![]() ![]() | Completed the primary vaccination series | 0..1 | boolean | |
![]() ![]() ![]() | Completed the booster series | 0..1 | boolean | |
![]() ![]() ![]() | Date when primary vaccination series was completed | 1..1 | date | Enable When: completedThePrimaryVaccinationSeries = |
![]() ![]() ![]() | HIV status | 0..1 | choice | Value Set: IMMZ.D.DE204 ValueSet for HIV status |
![]() ![]() ![]() | Type of poliovirus dose | 1..1 | choice | Value Set: IMMZ.D.DE212 ValueSet for Type of poliovirus dose |
![]() ![]() ![]() | Type of JE dose | 1..1 | choice | Value Set: IMMZ.D.DE216 ValueSet for Type of JE dose |
![]() ![]() ![]() | Type of TBE dose | 1..1 | choice | Value Set: IMMZ.D.DE220 ValueSet for Type of TBE dose |
![]() ![]() ![]() | Type of typhoid dose | 1..1 | choice | Value Set: IMMZ.D.DE225 ValueSet for Type of typhoid dose |
![]() ![]() ![]() | Type of cholera dose | 1..1 | choice | Value Set: IMMZ.D.DE229 ValueSet for Type of cholera dose |
![]() ![]() ![]() | Type of meningococcal dose | 1..1 | choice | Value Set: IMMZ.D.DE232 ValueSet for Type of meningococcal dose |
![]() ![]() ![]() | Type of hepatitis A dose | 0..1 | choice | Value Set: IMMZ.D.DE237 ValueSet for Type of hepatitis A dose |
![]() ![]() ![]() | Type of hepatitis B dose | 1..1 | choice | Value Set: IMMZ.D.DE254 ValueSet for Type of hepatitis B dose |
![]() ![]() ![]() | Vaccine type | 1..* | choice | Value Set: IMMZ.Z.VS ValueSet for vaccine types |
![]() ![]() ![]() | Date and time of vaccination | 1..1 | dateTime | |
![]() ![]() ![]() | Contact date | 0..1 | dateTime | |
![]() ![]() ![]() | ANC contact number | 0..1 | integer | |
![]() ![]() ![]() | Dose number | 1..1 | integer | |
![]() ![]() ![]() | Immunization event status | 1..1 | choice | Value Set: IMMZ.D.DE1 ValueSet for Immunization event status |
![]() ![]() ![]() | Reason vaccine was not administered | 1..1 | choice | Enable When: immunizationEventStatus = Value Set: IMMZ.D.DE5 ValueSet for Reason vaccine was not administered |
![]() ![]() ![]() | Vaccine brand | 1..1 | choice | Value Set: IMMZ.D.DE18 ValueSet for Vaccine brand |
![]() ![]() ![]() | Live vaccine | 0..1 | boolean | |
![]() ![]() ![]() | Country of vaccination | 1..1 | choice | Value Set: Iso 3166 Part 1: 3 Letter Codes |
![]() ![]() ![]() | Administrative area | 0..1 | choice | |
![]() ![]() ![]() | Vaccine manufacturer | 1..1 | choice | Value Set: IMMZ.D.DE23 ValueSet for Vaccine manufacturer |
![]() ![]() ![]() | Vaccine batch number | 0..1 | string | |
![]() ![]() ![]() | Vaccine market authorization holder | 1..1 | choice | Value Set: IMMZ.D.DE25 ValueSet for Vaccine market authorization holder |
![]() ![]() ![]() | Expiration date | 0..1 | date | |
![]() ![]() ![]() | Dose quantity | 0..1 | quantity | |
![]() ![]() ![]() | Health worker identifier | 0..1 | string | |
![]() ![]() ![]() | Total doses in series | 0..1 | integer | |
![]() ![]() ![]() | Disease targeted | 0..* | choice | Value Set: IMMZ.D.DE126 ValueSet for Disease targeted |
![]() ![]() ![]() | Due date of next dose | 0..1 | date | |
This value set expansion contains 4 concepts.
Code | System | Display | Definition |
DE259 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Primary series | Indicates that the client received the primary vaccination series of a product/antigen. This is also applicable for antigens with one dose |
DE260 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Dose 0 | Indicates that the client received a dose of a product/ antigen that is not a part of the primary vaccination series and is administered before the primary vaccination series is provided |
DE261 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Supplementary dose | Indicates that the client received a supplementary dose of a product/antigen |
DE262 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Booster dose | Indicates that the client received booster dose of a product/antigen |
This value set expansion contains 3 concepts.
Code | System | Display | Definition |
DE205 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | HIV-positive | The client is known to be HIV-positive |
DE206 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | HIV-negative | The client is known to be HIV-negative |
DE207 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Unknown | The client's HIV status is unknown |
This value set expansion contains 2 concepts.
Code | System | Display | Definition |
DE213 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | IPV | Inactivated polio vaccine (IPV) |
DE214 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | bOPV | Bivalent oral polio vaccine (bOPV) |
This value set expansion contains 3 concepts.
Code | System | Display | Definition |
DE217 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Inactivated Vero cell-derived vaccine | Inactivated Vero cell-derived JE vaccine type |
DE218 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Live attenuated vaccine | Live attenuated JE vaccine type |
DE219 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Live recombinant vaccine | Live recombinant JE vaccine type |
This value set expansion contains 4 concepts.
Code | System | Display | Definition |
DE221 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | FSME-Immun | FSME-Immun vaccine product, which is an inactivated whole-virus vaccine for TBE |
DE222 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Encepur | Encepur vaccine product, which is an inactivated viral vaccine for TBE |
DE223 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | TBE-Moscow | TBE-Moscow vaccine product, which is a vaccine for TBE |
DE224 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | EnceVir | EnceVir vaccine product, which is a vaccine for TBE |
This value set expansion contains 3 concepts.
Code | System | Display | Definition |
DE226 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Typbar-TCV | Typbar typhoid conjugate vaccine (Typbar-TCV) |
DE227 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | ViPS | Vi polysaccharide (ViPS) vaccine |
DE228 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Ty21a | Ty21a vaccine |
This value set expansion contains 2 concepts.
Code | System | Display | Definition |
DE230 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | WC vaccine | Killed whole-cell (WC) only cholera vaccine |
DE231 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | WC-rBS vaccine | Vaccine contains a mixture of the recombinant B subunit (rBS) of cholera toxin plus killed WC |
This value set expansion contains 4 concepts.
Code | System | Display | Definition |
DE233 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | MenA conjugate vaccine (5µg) | Monovalent serogroup A (MenA) conjugate vaccine (5µg) |
DE234 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Monovalent MenC conjugate | Monovalent MenC conjugate vaccine |
DE235 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Quadrivalent conjugate | Quadrivalent conjugate (A,C,W135,Y-D and A,C,W135,Y-CRM) vaccines |
DE252 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Polysaccharide vaccine | Polysaccharide vaccines not including polysaccharide-protein conjugate vaccines |
This value set expansion contains 2 concepts.
Code | System | Display | Definition |
DE238 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Live attenuated hepatitis A vaccine | Live attenuated hepatitis A vaccine |
DE239 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Inactivated hepatitis A vaccine | Inactivated hepatitis A vaccine |
This value set expansion contains 2 concepts.
Code | System | Display | Definition |
DE255 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Hepatitis B monovalent vaccine | Hepatitis B monovalent vaccine |
DE256 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Hepatitis B combination vaccine | Hepatitis B combination vaccine |
This value set expansion contains 3 concepts.
Code | System | Display | Definition |
DE2 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Completed | The immunization event was successfully carried out as intended |
DE3 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Entered in error | Immunization event record has been mistakenly created or entered into the system. Recorded information is incorrect or should not have been documented, though it is possible that real-world decisions were based on it |
DE4 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Not done | Planned immunization event was not carried out for some reason |
This value set expansion contains 12 concepts.
Code | System | Display | Definition |
DE6 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunity | Testing has shown that the client already has immunity to the agent targeted by the immunization |
DE7 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Medical precaution | The client currently has a medical condition for which the vaccine is contraindicated or for which precaution is warranted |
DE8 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Product out of stock | There was no supply of the product on hand to perform the service |
DE9 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Client objection | The client or their guardian objects to receiving the vaccine |
DE10 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Caregiver refusal | The client's caregiver refused the vaccine |
DE11 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Unspecified reason | The immunization event was not carried out for an unspecified reason |
DE12 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Client allergy to vaccine or component | The immunization event was not carried out because of client allergy to vaccine or component |
DE13 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunocompromised | The immunization event was not carried out because the client is immunocompromised |
DE14 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Chronic illness or condition | The immunization event was not carried out due a chronic illness or condition of the client |
DE15 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Acute illness | The immunization event was not carried out due to an acute illness present in the client |
DE16 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Had the disease | The immunization event was not carried out due to the client having had the disease |
DE17 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Immunization not carried out for other reasons | The immunization event was not carried out for other reasons |
This value set expansion contains 1 concepts.
Code | System | Display |
brand | http://smart.who.int/immunizations/CodeSystem/IMMZ.Ex | Example Brand |
This value set expansion contains 1 concepts.
Code | System | Display |
manufacturer | http://smart.who.int/immunizations/CodeSystem/IMMZ.Ex | Example Manufacturer |
This value set expansion contains 1 concepts.
Code | System | Display |
marketauth | http://smart.who.int/immunizations/CodeSystem/IMMZ.Ex | Example Market Authorization Holder |
This value set expansion contains 25 concepts.
Code | System | Display | Definition |
DE127 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Typhoid | The vaccine-preventable disease being targeted is typhoid |
DE128 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Influenza | The vaccine-preventable disease being targeted is influenza |
DE129 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Measles | The vaccine-preventable disease being targeted is measles |
DE133 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Pertussis | The vaccine-preventable disease being targeted is pertussis |
DE135 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Mumps | The vaccine-preventable disease being targeted is mumps |
DE136 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Varicella | The vaccine-preventable disease being targeted is varicella |
DE137 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Viral hepatitis A | The vaccine-preventable disease being targeted is viral hepatitis A |
DE139 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Tuberculosis | The vaccine-preventable disease being targeted is TB |
DE140 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Viral hepatitis B | The vaccine-preventable disease being targeted is viral hepatitis B |
DE141 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Haemophilus influenzae type b | The vaccine-preventable disease being targeted is Haemophilus influenzae type b (Hib) |
DE142 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Tetanus | The vaccine-preventable disease being targeted is tetanus |
DE143 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Rotavirus | The vaccine-preventable disease being targeted is rotavirus |
DE144 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Human papillomavirus | The vaccine-preventable disease being targeted is human papillomavirus (HPV) infection |
DE175 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Japanese encephalitis | The vaccine-preventable disease being targeted is Japanese encephalitis (JE) |
DE146 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Poliomyelitis | The vaccine-preventable disease being targeted is poliomyelitis (polio) |
DE176 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Diphtheria | The vaccine-preventable disease being targeted is diphtheria |
DE177 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Pneumococcal disease | The vaccine-preventable disease being targeted is pneumococcal |
DE178 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Rubella | The vaccine-preventable disease being targeted is rubella |
DE179 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Dengue | The vaccine-preventable disease being targeted is dengue |
DE180 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Rabies | The vaccine-preventable disease being targeted is rabies |
DE181 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Meningococcal | The vaccine-preventable disease being targeted is meningococcal |
DE182 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Cholera | The vaccine-preventable disease being targeted is cholera |
DE183 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Tick-borne encephalitis | The vaccine-preventable disease being targeted is tick-borne encephalitis (TBE) |
DE184 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | Yellow fever | The vaccine-preventable disease being targeted is yellow fever |
DE148 | http://smart.who.int/immunizations/CodeSystem/IMMZ.D | COVID-19 | The vaccine-preventable disease being targeted is coronovirus disease (COVID-19) |
This value set includes codes based on the following rules:
This value set expansion contains 19 concepts.
Code | System | Display | Definition |
DE6 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Hepatitis B-containing vaccines | Vaccine terminology codes for hepatitis B |
XM9V38 | http://id.who.int/icd/release/11/mms | Hepatitis B, purified antigen | |
836374004 | http://snomed.info/sct | Hepatitis B virus antigen-containing vaccine product | |
J07BC01 | http://www.whocc.no/atc | Hepatitis B, purified antigen | |
XM3G68 | http://id.who.int/icd/release/11/mms | Diphtheria, hepatitis B, tetanus vaccines | |
J07CA07 | http://www.whocc.no/atc | Diphtheria-hepatitis B-tetanus | |
XM32L7 | http://id.who.int/icd/release/11/mms | Hemophilus influenzae B and hepatitis B vaccines | |
871806004 | http://snomed.info/sct | Haemophilus influenzae type b and Hepatitis B virus antigens only vaccine product | |
J07CA08 | http://www.whocc.no/atc | Haemophilus influenzae B and hepatitis B | |
XM7JP3 | http://id.who.int/icd/release/11/mms | Diphtheria, hemophilus influenzae B, pertussis, tetanus, hepatitis B vaccines | |
J07CA11 | http://www.whocc.no/atc | Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B | |
XM0LT9 | http://id.who.int/icd/release/11/mms | Diphtheria, pertussis, poliomyelitis, tetanus, hepatitis B vaccines | |
J07CA12 | http://www.whocc.no/atc | Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | |
XM5XP9 | http://id.who.int/icd/release/11/mms | Diphtheria, hemophilus influenzae B, pertussis, tetanus-hepatitis B, meningococcus A + C vaccines | |
J07CA13 | http://www.whocc.no/atc | Diphtheria-haemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C | |
XM84S1 | http://id.who.int/icd/release/11/mms | Diphtheria, hepatitis B, tetanus, acellular pertussis, inactivated polio virus, haemophilus Influenzae type B vaccines | |
30937-7 | http://loinc.org | Long common name: Hepatitis B virus dose count in combination vaccine | |
J07CA09 | http://www.whocc.no/atc | Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | |
J07CA05 | http://www.whocc.no/atc | Diphtheria-hepatitis B-pertussis-tetanus |
This value set expansion contains 27 concepts.
Code | System | Display | Definition |
DE14 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Poliovirus-containing vaccines | Vaccine terminology codes for poliovirus |
XM0N50 | http://id.who.int/icd/release/11/mms | Poliomyelitis vaccines | |
1031000221108 | http://snomed.info/sct | Vaccine product containing Human poliovirus antigen (medicinal product) | |
J07BF | http://www.whocc.no/atc | Poliomyelitis vaccines | |
XM1LX9 | http://id.who.int/icd/release/11/mms | Diphtheria, hemophilus influenzae B, pertussis, poliomyelitis, tetanus vaccines | |
J07CA06 | http://www.whocc.no/atc | Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus | |
XM09Q7 | http://id.who.int/icd/release/11/mms | Diphtheria, pertussis, poliomyelitis, tetanus vaccines | |
J07CA02 | http://www.whocc.no/atc | Diphtheria-pertussis-poliomyelitis-tetanus | |
XM0LT9 | http://id.who.int/icd/release/11/mms | Diphtheria, pertussis, poliomyelitis, tetanus, hepatitis B vaccines | |
J07CA12 | http://www.whocc.no/atc | Diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B | |
XM8AW1 | http://id.who.int/icd/release/11/mms | Diphtheria, poliomyelitis, tetanus vaccines | |
J07CA01 | http://www.whocc.no/atc | Diphtheria-poliomyelitis-tetanus | |
XM01H1 | http://id.who.int/icd/release/11/mms | Hemophilus influenzae B and poliomyelitis vaccines | |
J07CA04 | http://www.whocc.no/atc | Haemophilus influenzae B and poliomyelitis | |
XM21E6 | http://id.who.int/icd/release/11/mms | Diphtheria tetanus, acellular pertussis, inactivated polio virus, haemophilus Influenzae type B vaccines | |
XM84S1 | http://id.who.int/icd/release/11/mms | Diphtheria, hepatitis B, tetanus, acellular pertussis, inactivated polio virus, haemophilus Influenzae type B vaccines | |
XM9JP8 | http://id.who.int/icd/release/11/mms | Diphtheria, tetanus, acellular pertussis, inactivated polio virus vaccines | |
XM5V19 | http://id.who.int/icd/release/11/mms | Poliomyelitis, trivalent, inactivated, whole virus | |
J07BF03 | http://www.whocc.no/atc | Poliomyelitis, trivalent, inactivated, whole virus | |
J07CA09 | http://www.whocc.no/atc | Diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B | |
XM79H3 | http://id.who.int/icd/release/11/mms | Poliomyelitis oral, bivalent, live attenuated | |
J07BF04 | http://www.whocc.no/atc | Poliomyelitis oral, bivalent, live attenuated | |
XM0VX8 | http://id.who.int/icd/release/11/mms | Poliomyelitis oral, monovalent live attenuated | |
J07BF01 | http://www.whocc.no/atc | Poliomyelitis oral, monovalent, live attenuated | |
XM0KZ1 | http://id.who.int/icd/release/11/mms | Poliomyelitis oral, trivalent, live attenuated | |
J07BF02 | http://www.whocc.no/atc | Poliomyelitis oral, trivalent, live attenuated | |
871740006 | http://snomed.info/sct | Inactivated whole Human poliovirus antigen only vaccine product |
This value set expansion contains 6 concepts.
Code | System | Display | Definition |
DE8 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | JE vaccines | Vaccine terminology codes for Japanese encephalitis (JE) |
XM0LB5 | http://id.who.int/icd/release/11/mms | Encephalitis, Japanese, inactivated, whole virus | |
836378001 | http://snomed.info/sct | Japanese encephalitis virus antigen-containing vaccine product | |
J07BA02 | http://www.whocc.no/atc | Encephalitis, Japanese, inactivated, whole virus | |
XM47S0 | http://id.who.int/icd/release/11/mms | Encephalitis, Japanese, live attenuated | |
J07BA03 | http://www.whocc.no/atc | Encephalitis, Japanese, live attenuated |
This value set expansion contains 5 concepts.
Code | System | Display | Definition |
DE20 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | TBE vaccines | Vaccine terminology codes for tick-borne encephalitis (TBE) |
836403007 | http://snomed.info/sct | Tick-borne encephalitis virus antigen-containing vaccine product | |
XM0RC1 | http://id.who.int/icd/release/11/mms | Encephalitis vaccines | |
XM8MP6 | http://id.who.int/icd/release/11/mms | Encephalitis, tick borne, inactivated, whole virus | |
J07BA01 | http://www.whocc.no/atc | Encephalitis, tick borne, inactivated, whole virus |
This value set expansion contains 14 concepts.
Code | System | Display | Definition |
DE21 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Typhoid vaccines | Vaccine terminology codes for typhoid |
XM8BU8 | http://id.who.int/icd/release/11/mms | Typhoid vaccines | |
J07AP | http://www.whocc.no/atc | Typhoid vaccines | |
XM3JA6 | http://id.who.int/icd/release/11/mms | Typhoid, hepatitis A vaccines | |
J07CA10 | http://www.whocc.no/atc | Typhoid-hepatitis A | |
XM33K4 | http://id.who.int/icd/release/11/mms | Typhoid, oral, live attenuated vaccines | |
J07AP01 | http://www.whocc.no/atc | Typhoid, oral, live attenuated | |
XM89G3 | http://id.who.int/icd/release/11/mms | Typhoid, inactivated, whole cell vaccines | |
J07AP02 | http://www.whocc.no/atc | Typhoid, inactivated, whole cell | |
XM3SF6 | http://id.who.int/icd/release/11/mms | Typhoid, purified polysaccharide antigen vaccines | |
J07AP03 | http://www.whocc.no/atc | Typhoid, purified polysaccharide antigen | |
XM9UB1 | http://id.who.int/icd/release/11/mms | Typhoid-paratyphoid vaccines | |
J07AP10 | http://www.whocc.no/atc | Typhoid, combinations with paratyphi types | |
J07AE51 | http://www.whocc.no/atc | Cholera, combinations with typhoid vaccine, inactivated, whole cell |
This value set expansion contains 12 concepts.
Code | System | Display | Definition |
DE2 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Cholera vaccines | Vaccine terminology codes for cholera |
XM29K4 | http://id.who.int/icd/release/11/mms | Cholera vaccines | |
836383009 | http://snomed.info/sct | Vibrio cholerae antigen-containing vaccine product | |
J07AE | http://www.whocc.no/atc | Cholera vaccines | |
XM3Z26 | http://id.who.int/icd/release/11/mms | Cholera, inactivated, whole cell vaccines | |
1001000221103 | http://snomed.info/sct | Inactivated whole Vibrio cholerae antigen only vaccine product in oral dose form | |
J07AE01 | http://www.whocc.no/atc | Cholera, inactivated, whole cell | |
XM72A0 | http://id.who.int/icd/release/11/mms | Cholera, live attenuated vaccines | |
1011000221100 | http://snomed.info/sct | Live attenuated Vibrio cholerae antigen only vaccine product in oral dose form | |
J07AE02 | http://www.whocc.no/atc | Cholera, live attenuated | |
XM1FT6 | http://id.who.int/icd/release/11/mms | Cholera, combinations with typhoid vaccine, inactivated, whole cell vaccines | |
J07AE51 | http://www.whocc.no/atc | Cholera, combinations with typhoid vaccine, inactivated, whole cell |
This value set expansion contains 16 concepts.
Code | System | Display | Definition |
DE10 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Meningococcal vaccines | Vaccine terminology codes for meningococcal |
XM2WV4 | http://id.who.int/icd/release/11/mms | Meningococcal vaccines | |
836401009 | http://snomed.info/sct | Neisseria meningitidis antigen-containing vaccine product | |
J07AH | http://www.whocc.no/atc | Meningococcal vaccines | |
XM92B2 | http://id.who.int/icd/release/11/mms | Meningococcal monovalent purified polysaccharides antigen vaccines | |
XM5LC2 | http://id.who.int/icd/release/11/mms | Meningococcal polyvalent purified polysaccharides antigen vaccines | |
XM18Y8 | http://id.who.int/icd/release/11/mms | Meningococcus C, purified polysaccharides antigen conjugated vaccines | |
XM2280 | http://id.who.int/icd/release/11/mms | Meningococcus A, purified polysaccharides antigen conjugated vaccines | |
XM9GJ1 | http://id.who.int/icd/release/11/mms | Meningococcus B, outer membrane vesicle vaccines | |
XM1X81 | http://id.who.int/icd/release/11/mms | Meningococcus B, multicomponent vaccines | |
XM37L5 | http://id.who.int/icd/release/11/mms | Meningococcus A, purified polysaccharides antigen vaccines | |
J07AH02 | http://www.whocc.no/atc | Other meningococcal monovalent purified polysaccharides antigen | |
J07AH05 | http://www.whocc.no/atc | Other meningococcal polyvalent purified polysaccharides antigen | |
871871008 | http://snomed.info/sct | Neisseria meningitidis serogroup A and C only vaccine product | |
871866001 | http://snomed.info/sct | Neisseria meningitidis serogroup C only vaccine product | |
871873006 | http://snomed.info/sct | Neisseria meningitidis serogroup A, C, W135 and Y only vaccine product |
This value set expansion contains 9 concepts.
Code | System | Display | Definition |
DE5 | http://smart.who.int/immunizations/CodeSystem/IMMZ.Z | Hepatitis A-containing vaccines | Vaccine terminology codes for hepatitis A |
XM6LL6 | http://id.who.int/icd/release/11/mms | Hepatitis vaccines | |
836375003 | http://snomed.info/sct | Hepatitis A virus antigen-containing vaccine product | |
XM2A12 | http://id.who.int/icd/release/11/mms | Hepatitis A, inactivated, whole virus | |
J07BC02 | http://www.whocc.no/atc | Hepatitis A, inactivated, whole virus | |
XM3JA6 | http://id.who.int/icd/release/11/mms | Typhoid, hepatitis A vaccines | |
J07CA10 | http://www.whocc.no/atc | Typhoid-hepatitis A | |
XM03Y7 | http://id.who.int/icd/release/11/mms | Combinations hepatitis vaccines | |
871803007 | http://snomed.info/sct | Hepatitis A and Hepatitis B virus antigens only vaccine product |